The pituitary tumor transforming gene 1 (PTTG-1): An immunological target for multiple myeloma

被引：0
|
作者：
Maurizio Chiriva-Internati
Raffaele Ferrari
Madhavi Prabhakar
Yuefei Yu
Luigi Baglioni
Jorge Moreno
Nicoletta Gagliano
Nicola Portinaro
Marjorie R Jenkins
Eldo E Frezza
Fred Hardwicke
Nicholas D'Cunha
W Martin Kast
Everardo Cobos
机构：
[1] Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center,Department of Microbiology and Immunology
[2] Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center,Division of Hematology and Oncology
[3] Texas Tech University Health Sciences Center and Southwest Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center,Division of Surgery
[4] University of Milan,Department of Human Morphology
[5] Obstetrics & Gynecology and Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine,Department of Internal Medicine
[6] Texas Tech University Health Sciences Center,Department of Pediatric Orthopedic Surgery
[7] Istituto Clinico Humanitas,Department of Molecular Microbiology & Immunology and Obstetrics & Gynecology, Norris Comprehensive Cancer Center
[8] University of Southern California,undefined
来源：
Journal of Translational Medicine | / 6卷
关键词：
Multiple Myeloma; Fluorescence Activate Cell Sorter; Human Normal Tissue; Multiple Myeloma Patient; Chronic Myelogenous Leukemia Cell Line;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Identification of ID-1 as a potential target gene of MMSET in multiple myeloma
    Hudlebusch, HR
    Theilgaard-Mönch, KS
    Lodahl, M
    Johnsen, HE
    Rasmussen, T
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (05) : 700 - 708
  • [2] PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
    Jacqueline E. Noll
    Kate Vandyke
    Duncan R. Hewett
    Krzysztof M. Mrozik
    Rachel J. Bala
    Sharon A. Williams
    Chung H. Kok
    Andrew CW Zannettino
    Journal of Hematology & Oncology, 8
  • [3] PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
    Noll, Jacqueline E.
    Vandyke, Kate
    Hewett, Duncan R.
    Mrozik, Krzysztof M.
    Bala, Rachel J.
    Williams, Sharon A.
    Kok, Chung H.
    Zannettino, Andrew C. W.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [4] Chromosome 1 instability in multiple myeloma: Aberrant gene expression, pathogenesis, and potential therapeutic target
    Luo, Saiqun
    Su, Tao
    Zhou, Xiang
    Hu, Wei-Xin
    Hu, Jingping
    FASEB JOURNAL, 2022, 36 (06):
  • [5] CIAPIN1 is a potential target for apoptosis of multiple myeloma
    Wang, Xiao-Bo
    Yan, Le-Ping
    Yuan, Li-Hua
    Lu, Bo
    Lin, Dong-Jun
    Xu, Xiao-Jun
    MATERIALS EXPRESS, 2019, 9 (09) : 1106 - 1111
  • [6] Expression of WT1 gene in multiple myeloma patients at diagnosis: is WT1 gene expression a useful marker in multiple myeloma?
    Saatci, Cetin
    Caglayan, A. Okay
    Kocyigit, Ismail
    Akalin, Hilal
    Kaynar, Leyla G.
    Altuntas, Fevzi
    Eser, Bulent
    Demir, Muzaffer
    Cetin, Mustafa
    Ozkul, Yusuf
    HEMATOLOGY, 2010, 15 (01) : 39 - 42
  • [7] Targeting SDF-1 in multiple myeloma tumor microenvironment
    Bouyssou, Juliette M. C.
    Ghobrial, Irene M.
    Roccaro, Aldo M.
    CANCER LETTERS, 2016, 380 (01) : 315 - 318
  • [8] PDK1 inhibition is a novel therapeutic target in multiple myeloma
    S Fujiwara
    Y Kawano
    H Yuki
    Y Okuno
    K Nosaka
    H Mitsuya
    H Hata
    British Journal of Cancer, 2013, 108 : 170 - 178
  • [9] MUC1-C is a target in lenalidomide resistant multiple myeloma
    Yin, Li
    Tagde, Ashujit
    Gali, Reddy
    Tai, Yu-Tzu
    Hideshima, Teru
    Anderson, Kenneth
    Avigan, David
    Kufe, Donald
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (06) : 914 - 926
  • [10] PDK1 inhibition is a novel therapeutic target in multiple myeloma
    Fujiwara, S.
    Kawano, Y.
    Yuki, H.
    Okuno, Y.
    Nosaka, K.
    Mitsuya, H.
    Hata, H.
    BRITISH JOURNAL OF CANCER, 2013, 108 (01) : 170 - 178
12345